Four homologous dyads with a phenothiazine donor, rigid variable-length p-xylene bridges, and a ruthenium(II) tris(2,2'-bipyridine) acceptor were synthesized. Photoexcitation of these donor-bridge-acceptor molecules in the presence of excess methylviologen generates a highly oxidizing Ru(III) intermediate, which triggers an intramolecular phenothiazine-to-ruthenium(III) electron transfer that is mediated by the oligo-p-xylene spacers. The rates for this process were determined using transient absorption spectroscopy, and they are found to decrease exponentially with increasing donor-acceptor distance. This decrease occurs with an attenuation factor beta of 0.77 A(-1) and is substantially stronger than for analogous donor-bridge-acceptor molecules where the acceptor is a rhenium(I) tricarbonyl diimine complex (beta = 0.52 A(-1)). This striking finding is interpreted in terms of a larger barrier to hole tunneling in the ruthenium dyads relative to the rhenium systems.
No takes yet. Share an insight, caveat, or question.
Hanss et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: